HLB Panagene (Biotechnology) Overview

  • Year Founded
  • 1976

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 83

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 4

HLB Panagene (Biotechnology) General Information

Description

HLB Panagene Co Ltd is a South Korea-based company that operates as a specialized bio venture company. The group is developing various technologies and products utilizing PNA (Peptide Nucleic Acid), an artificial gene.

Contact Information

Formerly Known As
Koram Panagene, Panagene
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 54, Techno 10-ro
  • Yuseong-gu
  • Daejeon, 34027
  • South Korea
+82
Primary Industry
Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 54, Techno 10-ro
  • Yuseong-gu
  • Daejeon, 34027
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HLB Panagene (Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 21-Jun-2023 Completed Generating Revenue
5. PIPE 20-Jun-2023 Completed Generating Revenue
4. PIPE Completed Generating Revenue
3. PIPE 21-Nov-2016 Completed Generating Revenue
2. IPO 16-Aug-2000 Completed Generating Revenue
1. Seed Round Completed Startup
To view HLB Panagene (Biotechnology)’s complete valuation and funding history, request access »

HLB Panagene (Biotechnology) Patents

HLB Panagene (Biotechnology) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022203297-A1 Target nucleic acid amplification method using guide probe and clamping probe and composition for amplifying target nucleic acid comprising same Inactive 22-Mar-2021
JP-2025118633-A Highly specific target nucleic acid amplification method and composition for amplifying target nucleic acid using the same Pending 24-Nov-2020
JP-2023551461-A Highly specific target nucleic acid amplification method and composition for target nucleic acid amplification using the same Pending 24-Nov-2020
EP-4253564-A1 Target nucleic acid amplification method with high specificity and target nucleic acid amplifying composition using same Pending 24-Nov-2020
EP-4253564-A4 Target nucleic acid amplification method with high specificity and target nucleic acid amplifying composition using same Pending 24-Nov-2020 C12Q1/6848
To view HLB Panagene (Biotechnology)’s complete patent history, request access »

HLB Panagene (Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HLB Panagene (Biotechnology) Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Atinum Investment Venture Capital Minority
Kiwoom Investment Venture Capital Minority
To view HLB Panagene (Biotechnology)’s complete investors history, request access »

HLB Panagene (Biotechnology) ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Machinery

Industry

Rank

Percentile

Industrial Machinery

Subindustry

Rank

Percentile

To view HLB Panagene (Biotechnology)’s complete esg history, request access »

HLB Panagene (Biotechnology) FAQs

  • When was HLB Panagene (Biotechnology) founded?

    HLB Panagene (Biotechnology) was founded in 1976.

  • Where is HLB Panagene (Biotechnology) headquartered?

    HLB Panagene (Biotechnology) is headquartered in Daejeon, South Korea.

  • What is the size of HLB Panagene (Biotechnology)?

    HLB Panagene (Biotechnology) has 83 total employees.

  • What industry is HLB Panagene (Biotechnology) in?

    HLB Panagene (Biotechnology)’s primary industry is Biotechnology.

  • Is HLB Panagene (Biotechnology) a private or public company?

    HLB Panagene (Biotechnology) is a Private company.

  • What is HLB Panagene (Biotechnology)’s current revenue?

    The current revenue for HLB Panagene (Biotechnology) is .

  • How much funding has HLB Panagene (Biotechnology) raised over time?

    HLB Panagene (Biotechnology) has raised $40.8M.

  • Who are HLB Panagene (Biotechnology)’s investors?

    Atinum Investment and Kiwoom Investment have invested in HLB Panagene (Biotechnology).

  • When was HLB Panagene (Biotechnology) acquired?

    HLB Panagene (Biotechnology) was acquired on 21-Jun-2023.

  • Who acquired HLB Panagene (Biotechnology)?

    HLB Panagene (Biotechnology) was acquired by HLB Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process